Epi-Oxa™ Cross-Linking (CXL) in New Jersey

Contact us

Epi-Oxa™, FDA-Approved to Slow the Progression of Keratoconus

At NJ Eye and Ear, we offer Epi-Oxa™ corneal cross-linking, an advanced FDA-approved approach designed to enhance both patient comfort and treatment precision. This treatment is designed to stop the progression of keratoconus and other corneal conditions, helping to preserve vision and reduce the need for more invasive treatments in the future.

Unlike traditional cross-linking methods that require removal of the outer corneal layer (epithelium), Epi-Oxa™ is performed with the epithelium intact—making it a less invasive, more comfortable experience for many patients.

What Is Corneal Cross-Linking?

Corneal cross-linking is a procedure that strengthens the cornea (the clear front surface of the eye) using a combination of vitamin B2 (riboflavin) eye drops and UV light.

This process helps:

  • Stabilize the cornea
  • Prevent further vision deterioration
  • Preserve long-term eye health 

Who is it for?

Cross-linking is most commonly recommended for patients with:



  • Keratoconus (progressive thinning of the cornea)
  • Corneal ectasia (often after LASIK)
  • Worsening vision due to corneal instability
  • 👉 Early detection is key—treating the condition sooner can help prevent permanent vision loss.

Why Epi-Oxa™ Cross-Linking?

  • More Comfortable Experience: No removal of the corneal surface means less irritation and a smoother recovery.
  • Faster Recovery Time: Patients can typically return to normal activities sooner compared to traditional methods.
  • Reduced Risk of Complications: Keeping the cornea intact helps lower the risk of infection and improves overall safety.
  • Advanced Oxygen-Enhanced Technology: Epi-Oxa™ uses optimized oxygen delivery to help maximize the effectiveness of treatment.
  • Proven Goal: Stabilization. Just like traditional cross-linking, the goal is to stop progression and protect long-term vision.

Traditional vs Epi-Oxa™ Cross-Linking

Meet our Specialist

Jimmy Hu, M.D. is a highly regarded ophthalmologist, medical scientist, and teacher. His specialities include state-of-the-art techniques and technology such as Meibomian Gland Probing. Additionally, as the Director of NJ Eye and Ear's LASIK Center, he specializes in Cataract, Corneal and Refractive Surgery.



Read Full Bio

Corneal Cross-linking FAQ's 

  • Does corneal cross-linking improve my vision?

    Eye movement is controlled by three pairs of muscles, which are attached to the outside of each eyeball. One set moves the eye right or left, while the other two sets move the eye up and down and control tilting movements. For normal vision, both eyes must line up together and focus on a single object. 

    Strabismus is caused by an eye muscle imbalance. A misplaced muscle or weak muscle causes one eye to turn in, out, up, or down. If the eyes turn in, the person is “cross-eyed.” If the eyes are turned out, the person is “wall-eyed.” Although the exact reason for the defect in the eye muscles is unknown, strabismus is frequently hereditary in nature. Fortunately, it is curable.

  • Is the procedure painful?

    The procedure itself is not painful, as numbing drops are used. After treatment, you may experience mild discomfort, light sensitivity, or a gritty feeling for a few days while the eye heals.

  • How long is the recovery process?

    Most patients return to normal activities within a few days, but full healing can take several weeks. Vision may fluctuate during this time before stabilizing.


  • How do I know if I need cross-linking?

    Cross-linking is typically recommended if tests show that your keratoconus or corneal condition is progressing. Early detection is key, which is why regular eye exams are important.


  • Is corneal cross-linking safe?

    Yes! Cross-linking is an FDA-approved, well-studied procedure with a strong track record for safety and effectiveness in slowing or stopping disease progression.